No Data
No Data
Intellia Therapeutics Reports Q3 EPS ($1.34), Consensus ($1.39)
Express News | Intellia Ended The Third Quarter Of 2024 With Approximately $944.7M In Cash, Cash Equivalents And Marketable Securities, The Cash Position Is Expected To Fund Operations Into Late 2026
Intellia Therapeutics 3Q Rev $9.11M >NTLA
Express News | Intellia Therapeutics Q3 Basic EPS USD -1.34
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
Express News | Intellia Therapeutics Q3 Net Income USD -135.712 Million
三和巴菲特 : Have you cried today? Baby
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 :
YWCYAPWEICHOY 叶伟财 OP 三和巴菲特 : Laughed.
71179109 : Intellia - 20% yesterday